Pavlyshyn Danylo - several months of treatment have passed
2018 08 23 Views: 264
Our ward Danylo
struggles against Crohn's disease. He returned home after a treatment at the Regional Children Clinical Hospital.
More than three months have passed from the first injection of immunobiological medicament "Humira". Control tests show that Danylo gets better, but it worth not stopping. In general, the boy feels good. Perhaps, his positive state was influenced by summer holidays, because he has a lot of free time and nothing overloads himself.
Treatment continues. We ask to help the child to buy medical products to decrease gastrointestinal inflammation.
Let’s remind you, Danylo Pavlyshyn has the chronic inflammation of the gastrointestinal tract - Crohn's disease. Treatment is very expensive and long lasting. The family spend more than UAH 10 000 on medicaments every month. Danylo's brother is a student too. The father does not live with them. So, it's difficult for the mother to provide child’s treatment in such circumstances.
They need your help
Denis is 15 years old. He has scoliosis. The boy has been being used a plastic corset for eight years, because of the strong curvature of the spine. Once doctors explained, the gullet that arose in the area of the spine was formed due to the rapid growth of the muscles. This caused scoliosis of 4 degrees. The spine did not maintained weight just got into the inside.
For his 9 years, Sergiy suffered over 50 fractures: he leaned on his elbow – and got a fracture of his hands, took off his sock or lingered slightly on another foot - a hip fracture. He just has removed the old gypsum, as again gets fractures. There are full eyes of tears, terrible pain - all this child experiences almost every month.
Oleg and Volodymyr are twins. However, even from their birth they have been diagnosed with a number of diseases. One-month old Volodymyr had VVS - membranous ventricular septal defect and equino-varus feet deformity. Oleg - deformation of both feet and congenital muscular dystrophy.
We are on